Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Inventory (2016 - 2024)

Perspective Therapeutics' Change in Inventory history spans 15 years, with the latest figure at $16000.0 for Q2 2024.

  • For Q2 2024, Change in Inventory rose 200.0% year-over-year to $16000.0; the TTM value through Jun 2025 reached $16000.0, up 107.08%, while the annual FY2023 figure was -$359000.0, N/A changed from the prior year.
  • Change in Inventory for Q2 2024 was $16000.0 at Perspective Therapeutics, up from -$27000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.9 million in Q2 2022 and bottomed at -$1.3 million in Q4 2021.
  • The 5-year median for Change in Inventory is $28000.0 (2020), against an average of $86388.9.
  • The largest annual shift saw Change in Inventory plummeted 5836.36% in 2021 before it skyrocketed 1343.61% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $22000.0 in 2020, then tumbled by 5836.36% to -$1.3 million in 2021, then skyrocketed by 106.02% to $76000.0 in 2022, then plummeted by 234.21% to -$102000.0 in 2023, then soared by 115.69% to $16000.0 in 2024.
  • Per Business Quant, the three most recent readings for CATX's Change in Inventory are $16000.0 (Q2 2024), -$27000.0 (Q1 2024), and -$102000.0 (Q4 2023).